|
[1]CAREY EJ, ALI AH, LINDOR KD.Primary biliary cirrhosis[J].Lancet, 2015, 386 (10003) :1565-1575.
|
|
[2]RUIZ A, MARIA T, GARCIA-BUEY L, et al.Hepatic osteodystrophy in patients with chronic autoimmune cholangiopathies:primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune cholangitis[J].Ann Rheum Dis, 2013, 71 (Suppl 3) :599-599.
|
|
[3]LESLIE WD, BERNSTEIN CN, LEBOFF MS.AGA technical review on osteoporosis in hepatic disorders[J].Gastroenterology, 2003, 125 (3) :941-966.
|
|
[4]FLOREANI A, MEGA A, CAMOZZI V, et al.Is osteoporosis a peculiar association with primary biliary cirrhosis?[J].World J Gastroenterol, 2005, 11 (34) :5347-5350.
|
|
[5]MOUNACH A, OUZZIF Z, WARIAGHLI G, et al.Primary biliary cirrhosis and osteoporosis:a case-control study[J].J Bone Miner Metab, 2008, 26 (4) :379-384.
|
|
[6]ZHAO J, LI W, LIANG CQ, et al.Liver cirrhosis and the risk of fracture:a meta-analysis[J].J Clin Hepatol, 2017 (6) :1112-1115. (in Chinese) 赵健, 李伟, 梁才全, 等.肝硬化与骨折发生风险相关性的Meta分析[J].临床肝胆病杂志, 2017 (6) :1112-1115.
|
|
[7]GAO XS, DUAN XF.Progress of hepatic osteoporosis in liver cirrhosis[J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (4) :14-18. (in Chinese) 高学松, 段雪飞.肝硬化合并肝性骨病的研究进展[J/CD].中国肝脏病杂志:电子版, 2015, 7 (4) :14-18.
|
|
[8]ZHAO J, LI W, CAO J, et al.Association between primary biliary cholangitis and fracture:a meta-analysis[J].Clin Res Hepatol Gastroenterol, 2017.[Epub ahead of print]
|
|
[9]KOHLI SS, KOHLI VS.Role of RANKL-RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications[J].Indian J Endocrinol Metab, 2011, 15 (3) :175-181.
|
|
[10]DRAKE M T, CLARKE BL, LEWIECKI EM.The pathophysiology and treatment of osteoporosis[J].Clin Ther, 2015, 37 (8) :1837-1850.
|
|
[11]HERLONG HF, RECKER RR, MADDREY WC.Bone disease in primary biliary cirrhosis:histologic features and response to 25-hydroxyvitamin D[J].Gastroenterology, 1982, 83 (1 Pt 1) :103-108.
|
|
[12]GAO X, ZHANG Y, LIU T, et al.Clinical study of hepatic osteoporosis in primary biliary cirrhosis[J].Hepatol Int, 2017, 11 (1) :s591.
|
|
[13]KRISHNAMOORTHY R, GRANT A, SHELDON P, et al.Fracture prevalence and vitamin D status in primary biliary cirrhosis:the Leicestershire experience[J].Gut, 2012, 61 (Suppl 2) :a410-a411.
|
|
[14]GUO GY, SHI YQ, WANG L, et al.Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis[J].Aliment Pharmacol Ther, 2015, 42 (2) :221-230.
|
|
[15]PARES A, GUANABENS N.Osteoporosis in primary biliary cirrhosis:pathogenesis and treatment[J].Clin Liver Dis, 2008, 12 (2) :407-424.
|
|
[16]ANGULO P, JORGENSEN RA, KEACH JC, et al.Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid[J].Hepatology, 2000, 31 (2) :318-323.
|
|
[17]GUICHELAAR MM, MALINCHOC M, SIBONGA J, et al.Bone metabolism in advanced cholestatic liver disease:analysis by bone histomorphometry[J].Hepatology, 2002, 36 (1) :895-903.
|
|
[18]RUIZ-GASPA S, GUANABENS N, ENJUANES A, et al.Lithocholic acid downregulates vitamin D effects in human osteoblasts[J].Eur J Clin Invest, 2010, 40 (1) :25-34.
|
|
[19]KOSHIHARA Y, HOSHI K, OKAWARA R, et al.Vitamin Kstimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture[J].J Endocrinol, 2003, 176 (3) :339-348.
|
|
[20]COLLIER JD, NINKOVIC M, COMPSTON JE.Guidelines on the management of osteoporosis associated with chronic liver disease[J].Gut, 2002, 50 (Suppl 1) :1-9.
|
|
[21]KEMMLER W, ENGELKE K, von STENGEL S.Long-term exercise and bone mineral density changes in postmenopausal womenare there periods of reduced effectiveness?[J].J Bone Miner Res, 2016, 31 (1) :215-222.
|
|
[22]BLACK DM, ROSEN CJ.Clinical practice.Postmenopausal osteoporosis[J].N Engl J Med, 2016, 374 (3) :254-262.
|
|
[23]SHIOMI S, MASAKI K, HABU D, et al.Calcitriol for bone disease in patients with cirrhosis of the liver[J].J Gastroenterol Hepatol, 1999, 14 (6) :547-552.
|
|
[24]SHIOMI S, MASAKI K, HABU D, et al.Calcitriol for bone loss in patients with primary biliary cirrhosis[J].J Gastroenterol, 1999, 34 (2) :241-245.
|
|
[25]GUANABENS N, CERDA D, MONEGAL A, et al.Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis[J].Gastroenterology, 2010, 138 (7) :2348-2356.
|
|
[26]JANSEN JP, BERGMAN GJ, HUELS J, et al.The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis:a network meta-analysis[J].Semin Arthritis Rheum, 2011, 40 (4) :275-284.
|
|
[27]GUANABENS N, PARES A, ROS I, et al.Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis[J].Am J Gastroenterol, 2003, 98 (10) :2268-2274.
|
|
[28]ZEIN CO, JORGENSEN RA, CLARKE B, et al.Alendronate improves bone mineral density in primary biliary cirrhosis:a randomized placebo-controlled trial[J].Hepatology, 2005, 42 (4) :762-771.
|
|
[29]RUDIC JS, GILJACA V, KRSTIC MN, et al.Bisphosphonates for osteoporosis in primary biliary cirrhosis[J].Cochrane Database Syst Rev, 2011 (12) :d9144.
|
|
[30]GUANABENS N, MONEGAL A, CERDA D, et al.Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis[J].Hepatology, 2013, 58 (6) :2070-2078.
|
|
[31]RUDIC JS, POROPAT G, KRSTIC MN, et al.Hormone replacement for osteoporosis in women with primary biliary cirrhosis[J].Cochrane Database Syst Rev, 2011, 12 (12) :d9146.
|
|
[32]MENON KV, ANGULO P, BOE GM, et al.Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis[J].Am JGastroenterol, 2003, 98 (4) :889-892.
|
|
[33]PEREIRA SP, O'DONOHUE J, MONIZ C, et al.Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis:results of a 1-year controlled trial[J].Aliment Pharmacol Ther, 2004, 19 (5) :563-570.
|
|
[34]LEVY C, HARNOIS DM, ANGULO P, et al.Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis:results of a pilot study[J].Liver Int, 2005, 25 (1) :117-121.
|
|
[35]FLOREANI A, CHIARAMONTE M, GIANNINI S, et al.Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment[J].J Hepatol, 1991, 12 (2) :217-223.
|
|
[36]FLOREANI A, ZAPPALA F, FRIES W, et al.A 3-year pilot study with 1, 25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis[J].J Clin Gastroenterol, 1997, 24 (4) :239-244.
|
DownLoad: